Image

FamCe-HLP- Family-centered Obesity Management Program in Primary Care Settings

Recruiting
6 - 12 years of age
Both
Phase N/A

Powered by AI

Overview

This clinical trial aims to compare the adiposity and weight status among mother-child dyads with overweight or obesity who receive the Fam-Ce-HLP intervention with the mother-child dyads with overweight or obesity who did not receive the intervention. The main question[s] it aims to answer are:

  • Is there a significant difference in the adiposity and weight status of mother-child dyads with overweight or obesity who received the Fam-Ce-HLP intervention compared with the mother-child dyads with overweight or obesity who did not receive the intervention?
  • Is there a significant difference in the health behaviors, obesity stage level, and ripple effect of mother-child dyads with overweight or obesity who received the Fam-Ce-HLP intervention compared with the mother-child dyads with overweight or obesity who did not receive the intervention? Participants will be asked to attend a seven-month program comprising two primary therapies: a three-month intensive behavioral therapy (IBT) and a four-month maintenance behavioral therapy (MBT).

Researchers will compare the intervention group with the treatment-as-usual group (control group) to see if there is a difference in adiposity, weight status, health behaviors, obesity stage level, and ripple effect.

Eligibility

Inclusion Criteria:

  • Mother and child dyads with the presence of overweight or obesity (stages 0 to 2)
  • Being Omani
  • Mother age 18 years or more
  • Child age 6 to 12 years
  • Mother understand, write, and read in Arabic
  • Eligible to receive the health center's services based on their area of residence
  • Has medical clearance to participate in individual exercise sessions
  • Ability to understand study procedures and to comply with them for the entire length of the study.

Exclusion Criteria:

  • Mother or child currently receiving an obesity-related program
  • Mother or child currently on obesity-related procedures
  • Mother or child with a history of obesity-related surgeries in the last 5 years
  • Mother or child is in obesity stage 3 or 4 based on the Edmonton obesity staging system
  • Mother who is pregnant during the study time

Study details

Childhood Obesity, Family, Behavior, Health, Lifestyle

NCT06394882

Oman Ministry of Health

17 May 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.